The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer
Open accessAbstract
Cancer cells must integrate multiple biosynthetic demands to drive indefinite proliferation. How these key cellular processes, such as metabolism and protein synthesis, crosstalk to fuel cancer cell growth is unknown. Here, we uncover the mechanism by which the Myc oncogene coordinates the production of the two most abundant classes of cellular macromolecules, proteins, and nucleic acids in cancer cells. We find that a single rate-limiting enzyme, phosphoribosyl-pyrophosphate synthetase 2 (PRPS2), promotes increased nucleotide biosynthesis in Myc-transformed cells. Remarkably, Prps2 couples protein and nucleotide biosynthesis through a specialized cis-regulatory element within the Prps2 5' UTR, which is controlled by the oncogene and translation initiation factor eIF4E downstream Myc activation. We demonstrate with a Prps2 knockout mouse that the nexus between protein and nucleotide biosynthesis controlled by PRPS2 is crucial for Myc-driven tumorigenesis. Together, these studies identify a translationally anchored anabolic circuit critical for cancer cell survival and an unexpected vulnerability for "undruggable" oncogenes, such as Myc. PAPERFLICK:
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the c-myc-regulated targets are phosphoribosyl pyrophosphate synthetase 2 (PRPS2), which catalyzes a first step of purine biosynthesis, as well as carbamoyl phosphate synthetase II (CAD), which initiates the pyrimidine ring-building cascade (Cunningham et al., 2014; Eberhardy and Farnham, 2001; Mannava et al., 2008).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Cunningham et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Hwang, T., & Shaka, A. J. (1995) · Journal of Magnetic Resonance Series A · doi:10.1006/jmra.1995.1047 · Cited by 1,929
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Dieterle, F., Ross, A., Schlotterbeck, G., & Senn, H. (2006) · Analytical Chemistry · doi:10.1021/ac051632c · Cited by 1,772
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
Self-citationMetabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α
Gerhart‐Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S., Mostoslavsky, R., Alt, F. W., Wu, Z., & Puigserver, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601633 · Cited by 1,294
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.001 · Cited by 949
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858
HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and Proliferation
Gordan, J. D., Thompson, C. B., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.006 · Cited by 819
Hochedlinger, K., Yamada, Y., Beard, C., & Jaenisch, R. (2005) · Cell · doi:10.1016/j.cell.2005.02.018 · Cited by 747
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1
Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739
B lymphocyte-specific, Cre-mediated mutagenesis in mice
Rickert, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.6.1317 · Cited by 729
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type
Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.015 · Cited by 639
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W. G., Londei, P., Cordon‐Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 592
Bywater, M. J., Poortinga, G., Sanij, E., Hein, N., Peck, A., Cullinane, C. M., Wall, M., Cluse, L. A., Drygin, D., Anderes, K. L., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.019 · Cited by 561
Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
Eilers, M., Picard, D., Yamamoto, K. R., & Bishop, J. M. (1989) · Nature · doi:10.1038/340066a0 · Cited by 458
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Barna, M., Pusic, A. D., Zollo, O., Costa, M. J. D. C., Kondrashov, N., Rego, E. M., Rao, P. H., & Ruggero, D. (2008) · Nature · doi:10.1038/nature07449 · Cited by 454
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Hemann, M. T., Bric, A., Teruya‐Feldstein, J., Herbst, A., Nilsson, J. A., Cordon‐Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452
Hsieh, A. C., Costa, M., Zollo, O., Davis, C., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., & Ruggero, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.021 · Cited by 434
Harris, A. W., Pinkert, C. A., Crawford, M., Langdon, W. Y., Brinster, R. L., & Adams, J. M. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.2.353 · Cited by 432
Doherty, J. R., Yang, C., Scott, K. E. N., Cameron, M. D., Fallahi, M., Li, W., Hall, M. A., Amelio, A. L., Mishra, J. K., Li, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2034 · Cited by 411
Growth control and ribosome biogenesis
Lempiäinen, H., & Shore, D. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.09.002 · Cited by 401
Bélteki, G. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni051 · Cited by 382
c-Myc enhances protein synthesis and cell size during B lymphocyte development
Iritani, B. M., & Eisenman, R. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13180 · Cited by 364
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
Tong, X., Zhao, F., & Thompson, C. B. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.002 · Cited by 351
Smolenski, R. T., Lachno, D. R., Ledingham, S. J. M., & Yacoub, M. H. (1990) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)82125-8 · Cited by 322
Global Regulation of Nucleotide Biosynthetic Genes by c-Myc
Liu, Y.-C., Li, F., Handler, J., Huang, C. R. L., Xiang, Y., Neretti, N., Sedivy, J. M., Zeller, K. I., & Dang, C. V. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002722 · Cited by 317
Metabolic Pathway Alterations that Support Cell ProliferationPreprint
Heiden, M. G. V., Lunt, S. Y., Dayton, T. L., Fiske, B. P., Israelsen, W. J., Mattaini, K. R., Vokes, N. I., Stephanopoulos, G. N., Cantley, L. C., Metallo, C. M., et al. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010900 · Cited by 309
Pourdehnad, M., Truitt, M., Siddiqi, I. N., Ducker, G. S., Shokat, K. M., & Ruggero, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310230110 · Cited by 295
Ribosomal protein L24 defect in Belly spot and tail (Bst), a mouse Minute
Oliver, E. R., Saunders, T. L., Tarlé, S. A., & Glaser, T. (2004) · Development · doi:10.1242/dev.01268 · Cited by 288
A unique glucose-dependent apoptotic pathway induced by c-Myc
Shim, H., Chun, Y. S., Lewis, B. C., & Dang, C. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1511 · Cited by 286
Aird, K. M., Zhang, G., Li, H., Tu, Z., Bitler, B. G., Garipov, A., Wu, H., Wei, Z., Wagner, S. N., Herlyn, M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.004 · Cited by 285
Genetic analysis of chemoresistance in primary murine lymphomas
Schmitt, C. A., Rosenthal, C., & Lowe, S. W. (2000) · Nature Medicine · doi:10.1038/79542 · Cited by 280
Zuber, J., McJunkin, K., Fellmann, C., Dow, L. E., Taylor, M. J., Hannon, G., & Lowe, S. (2010) · Nature Biotechnology · doi:10.1038/nbt.1720 · Cited by 277
Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells
Mannava, S., Grachtchouk, V., Wheeler, L. J., Im, M., Zhuang, D., Slavina, E. G., Mathews, C. K., Shewach, D. S., & Nikiforov, M. A. (2008) · Cell Cycle · doi:10.4161/cc.6390 · Cited by 257 · cited 2×
“…cellular machineries, including those promoting protein synthesis, glycolysis, glutaminolysis , and nucleotide synthesis, all of which are vital for sustaining cancer cell survival (Dang, 2010; Gordan et al., 2007; Liu et al., 2008; Mannava et al., 2008; Morrish et al., 2008; Wise et al., 2008).”
Jones, R. M., Branda, J. A., Johnston, K. A., Polymenis, M., Gadd, M. A., Rustgi, A. K., Callanan, L., & Schmidt, E. V. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4754 · Cited by 240
Ribosome biogenesis: of knobs and RNA processing
Granneman, S. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.016 · Cited by 239
Dysregulation of the basal RNA polymerase transcription apparatus in cancer
Bywater, M. J., Pearson, R. B., McArthur, G. A., & Hannan, R. D. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3496 · Cited by 224
Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
Hsieh, A. C., & Ruggero, D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0433 · Cited by 199
RNA polymerases I and III, non-coding RNAs and cancer
White, R. J. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.10.003 · Cited by 190
Quantitation of cellular deoxynucleoside triphosphates
Ferraro, P., Franzolin, E., Pontarin, G., Reichard, P. A., & Bianchi, V. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1141 · Cited by 163
Ludwig, C., Easton, J. M., Lodi, A., Tiziani, S., Manzoor, S. E., Southam, A. D., Byrne, J. J., Bishop, L. M., He, S., Arvanitis, T. N., et al. (2011) · Metabolomics · doi:10.1007/s11306-011-0347-7 · Cited by 147
Regulation of Ribosomal Protein mRNA Content and Translation in Growth-Stimulated Mouse Fibroblasts
Geyer, P., Meyuhas, O., Perry, R. P., & Johnson, L. F. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.6.685-693.1982 · Cited by 144
The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry
Morrish, F. M., Neretti, N., Sedivy, J. M., & Hockenbery, D. M. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5739 · Cited by 130
NMRLAB—Advanced NMR Data Processing in Matlab
Günther, U. L., Ludwig, C., & Rüterjans, H. (2000) · Journal of Magnetic Resonance · doi:10.1006/jmre.2000.2071 · Cited by 97
mRNA Translation and Energy Metabolism in Cancer: The Role of the MAPK and mTORC1 PathwaysPreprint
Topisirović, I., & Sonenberg, N. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010785 · Cited by 96
Nosal, J. M., Switzer, R. L., & Becker, M. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82187-1 · Cited by 81
Ronen, S. M., Jackson, L. E., Beloueche‐Babari, M., & Leach, M. O. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1663 · Cited by 76
Becker, M. A., Heidler, S. A., Bell, G. I., Seino, S., Beau, M. M. L., Westbrook, C. A., Neuman, W. L., Shapiro, L. J., Mohandas, T. K., Roessler, B. J., et al. (1990) · Genomics · doi:10.1016/0888-7543(90)90043-t · Cited by 67
Enigmatic MYC Conducts an Unfolding Systems Biology Symphony
Dang, C. V. (2010) · Genes & Cancer · doi:10.1177/1947601910378742 · Cited by 65
Bélteki, G. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki559 · Cited by 61
White, J. C., Loftfield, S., & Goldman, I. D. (1975) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10637-8 · Cited by 55
Decreased purine synthesis during amino acid starvation of human lymphoblasts.
Boss, G. R., & Erbe, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34712-4 · Cited by 35
Graves, J. A., Rothermund, K. D., Wang, T., Qian, W., Houten, B. V., & Prochownik, E. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013717 · Cited by 23
Cited by
Sorted by citations
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
Hoxhaj, G., & Manning, B. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0216-7 · Cited by 2,137
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,435
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088
Regulation of mammalian nucleotide metabolism and biosynthesis
Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959
Metadata
- Authors
- Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Ruggero, Davide
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 157
- Issue
- 5
- Pages
- 1088-1103
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4140650
- OpenAlex
- W2073120856
- Cited by
- 260
- References
- 57
- Citations by year
- 2026: 20 · 2025: 18 · 2024: 30 · 2023: 17 · 2022: 24 · 2021: 24 · 2020: 20 · 2019: 23 · 2018: 13 · 2017: 16 · 2016: 25 · 2015: 23 · 2014: 7
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-07-31)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Leukemia and Lymphoma Society
- Gladstone Institutes
- Regeneron Pharmaceuticals
- National Institutes of Health
- University of California, Davis
- National Human Genome Research Institute (U01HG004085, U01HG004080)
- National Cancer Institute (R01 CA130812, R01CA140456, R01CA154915, R01CA154916)
- National Center for Research Resources (U42RR024244)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PRPS2, phosphoribosylpyrophosphate synthetase, MYC oncogene, nucleotide synthesis, protein synthesis, rate-limiting enzyme, eIF4E, translation initiation, anabolic metabolism, carcinogenesis, tumor cell proliferation
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Burkitt Lymphoma, Cells, Cultured, Humans, Isoenzymes, Molecular Sequence Data, Nucleotides, Ribose-Phosphate Pyrophosphokinase, Protein Biosynthesis, Proto-Oncogene Proteins c-myc, Mice, Knockout, 5' Untranslated Regions, Eukaryotic Initiation Factor-4E, NIH 3T3 Cells, Cell Line, Tumor, Mice, Embryonic Stem Cells, Gene Knockdown Techniques, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
